Top Biotech Companies (3,703)
Dexcom Corporation is a pioneer and global leader in continuous glucose monitoring (CGM). Dexcom began as a small company with a big dream: To forever change how diabetes is managed. To unlock information and insights that drive better health outcomes. Here we are 25 years later, having pioneered an industry. And we're just getting started. We are broadening our...
Dexcom's Top Stability & Growth Strengths
Strong Market Position & Advantage: Dexcom is repeatedly portrayed as a co-leader globally and the U.S. leader in CGM, supported by deep integrations with automated insulin delivery systems and a durable duopoly structure. This positioning reflects sustained adoption of its G7 platform and scale advantages.
Strong Revenue Growth: Recent results and guidance indicate consistent double-digit year-over-year growth with expanding margins. Management communications highlight ongoing momentum into 2026 supported by continued platform rollouts.
Market Expansion: The launch of an over-the-counter sensor and extended-wear G7 broaden addressable users beyond intensive insulin therapy. International uptake and clinical data in non‑insulin type 2 populations further extend the growth runway.
University Health Network is Canada's largest research hospital and a public research and teaching hospital network in Toronto, Ontario, known for its scope of research and complexity of cases.
Topos Bio is an AI-powered biotechnology company developing therapies for intrinsically disordered proteins (IDPs) by creating an AI-native drug discovery platform that models protein ensembles to tackle previously undruggable targets.
Galatea Bio is an innovative, venture-backed biotechnology company dedicated to advancing precision health for all. The company leverages world-class ancestry algorithms to better understand underserved Latin American populations while maintaining a strong commitment to ethical research. It partners with pharmaceutical and life sciences organizations to design and execute projects that utilize human genetic diversity to solve acute problems in biomedicine.
Avantpage is a language access solutions provider specializing in professional translation, localization, and interpretation services in over 150 languages. The company serves government, healthcare, life sciences, and other regulated industries, focusing on bridging communication gaps for immigrants and Limited English Proficient populations to create equity and opportunity.
Parent Project Muscular Dystrophy (PPMD) is a nonprofit organization dedicated to ending Duchenne muscular dystrophy. For over three decades, PPMD has been committed to exploring and supporting every therapeutic possibility. They take a cutting-edge approach to accelerate the development of treatments, improve care standards, and advocate for federal funding, ensuring that safe and effective therapies reach every person impacted by...
Millennium Health is an accredited specialty laboratory with over a decade of experience delivering timely, accurate, clinically-actionable information through our nationwide medication monitoring and drug testing services. Drug testing is used by substance use disorder and pain management providers to obtain objective information about patients’ recent use of prescription medications and/or illicit drugs and helps monitor the effectiveness of treatment...
Nurix Therapeutics discovers drugs that harness the body's natural process to control protein levels. Our drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells, as a unique therapeutic approach to treat a broad range of diseases. Our focus is on developing drugs to treat cancer including novel, small molecule immuno-oncology agents
Output Biosciences is the world’s first preventative therapeutics company that extends human healthspan by combating chronic disease.
Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with...
Proteins are the most advanced nanotechnology we know of. At Adaptyv Bio we’re building a next-gen protein foundry to allow you to synthesize and test any protein you design.
Every day millions of people feel the impact of our intelligent devices, advanced analytics and artificial intelligence. As a leading global medical technology and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around...
GE Healthcare's Top Stability & Growth Strengths
Strong Market Position & Advantage: GE HealthCare is positioned as a top-tier global medical technology player with leadership across diagnostic imaging, ultrasound, and pharmaceutical diagnostics, supported by a very large installed base and operations in over 160 countries. Scale and portfolio breadth across major modalities and care settings are repeatedly presented as durable advantages that support recurring service, upgrades, and consumables/software revenue.
Innovation-Driven Growth: R&D investment exceeding $1B annually and an active pipeline of many products in imaging, digital health, and in vitro diagnostics indicate a sustained innovation engine. The emphasis on AI-enabled devices and new product introductions (e.g., photon-counting CT and other launches) is framed as a multi-year driver that should increase contribution to revenue over time.
Resilient & Sustainable Growth: Orders and backlog signals (book-to-bill above 1.0, growing orders, and a reported record backlog) suggest demand is keeping pace with shipments and provides forward visibility. Guidance for continued low-single-digit organic growth alongside expectations for EPS growth and meaningful free cash flow points to steady, defensible expansion rather than cyclical contraction.
Sobi is an international biopharmaceutical company dedicated to transforming the lives of people living with rare diseases. Focused on haematology, immunology, and specialty care, the company develops and delivers innovative therapies and breakthrough medicines to patients globally. They aim to improve the lives of those with rare and debilitating diseases through scientific innovation and extensive patient support networks.
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. We are focused on the development of proprietary therapeutics using a recently developed biological tool known as the CRISPR/Cas9 system. The promise of the CRISPR/Cas9 system is the driving...
Cerapedics is a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair by healing bones faster and at higher rates, utilizing proprietary technology such as the P-15 Peptide.
LFB is a biopharmaceutical group that develops, manufactures and markets medicinal products for the treatment of serious and often rare diseases in several major therapeutic fields, namely Hemostasis, Immunology and Intensive Care. With most of its products indicated for serious and rare diseases, LFB is a major player in this area. The LFB Group is the leading manufacturer of plasma-derived medicinal...
Alphazyme was founded in 2018 by Christopher Benoit, Stephana Petrino and Chad Decker. Our experienced team has a track record of success and a passion for supporting molecular biology innovators. Our mission is to be the world’s premier partner for custom, industrial-scale, molecular biology enzymes. We are enzyme development and production experts, and partner with the manufacturers of nucleic acid therapies and...
We are a biotechnology company integrating AI, computation and biological automation to accelerate the design of small molecule and protein therapeutics. Our mission is to decrease the timeline and cost of drug development, while improving the success rate of bring innovative medicines to patients in need. We have two drug discovery engines - ELVIS™ and ROSALYND™ - that enable the design...
We've experienced the significant gaps in our collective ability, as a medical and research community, to access and understand disease-defining biology when it matters most. To address this, we've developed a simple blood test to uncover actionable disease-defining transcriptional biology. Our unique genome-wide platform profiles circulating chromatin and the DNA methylome to deliver resolution into the dynamic activity of individual...
Sharp Services is a global leader in pharmaceutical CDMO services, specializing in commercial packaging, clinical trial services, and sterile manufacturing. They partner with pharmaceutical and biopharmaceutical clients, offering comprehensive solutions and support from phase I trials through to commercial launch and lifecycle management to help bring important medicines to patients worldwide.
